Orthofix Medical Inc (OFIX)
17.60
-1.04
(-5.58%)
USD |
NASDAQ |
Nov 14, 16:00
17.60
0.00 (0.00%)
After-Hours: 20:00
Orthofix Medical Research and Development Expense (Quarterly): 17.29M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 17.29M |
| June 30, 2024 | 18.05M |
| March 31, 2024 | 19.49M |
| December 31, 2023 | 18.94M |
| September 30, 2023 | 18.56M |
| June 30, 2023 | 19.42M |
| March 31, 2023 | 23.31M |
| December 31, 2022 | 13.15M |
| September 30, 2022 | 11.94M |
| June 30, 2022 | 12.76M |
| March 31, 2022 | 11.21M |
| December 31, 2021 | 13.24M |
| September 30, 2021 | 12.36M |
| June 30, 2021 | 13.12M |
| March 31, 2021 | 10.90M |
| December 31, 2020 | 10.36M |
| September 30, 2020 | 9.962M |
| June 30, 2020 | 8.765M |
| March 31, 2020 | 9.964M |
| December 31, 2019 | 8.446M |
| September 30, 2019 | 7.982M |
| June 30, 2019 | 8.98M |
| March 31, 2019 | 9.229M |
| December 31, 2018 | 8.792M |
| September 30, 2018 | 9.598M |
| Date | Value |
|---|---|
| June 30, 2018 | 7.891M |
| March 31, 2018 | 6.937M |
| December 31, 2017 | 8.454M |
| September 30, 2017 | 6.935M |
| June 30, 2017 | 6.887M |
| March 31, 2017 | 7.424M |
| December 31, 2016 | 7.509M |
| September 30, 2016 | 6.858M |
| June 30, 2016 | 6.796M |
| March 31, 2016 | 7.64M |
| December 31, 2015 | 7.57M |
| September 30, 2015 | 6.523M |
| June 30, 2015 | 6.451M |
| March 31, 2015 | 5.845M |
| December 31, 2014 | 6.176M |
| September 30, 2014 | 6.572M |
| June 30, 2014 | 6.313M |
| March 31, 2014 | 5.933M |
| December 31, 2013 | 6.115M |
| September 30, 2013 | 6.361M |
| June 30, 2013 | 8.551M |
| March 31, 2013 | 5.741M |
| December 31, 2012 | 5.417M |
| September 30, 2012 | 6.858M |
| June 30, 2012 | 9.252M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
8.446M
Minimum
Dec 2019
23.31M
Maximum
Mar 2023
14.06M
Average
12.94M
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp | 377.00M |
| Globus Medical Inc | 35.38M |
| Perspective Therapeutics Inc | 9.275M |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |